Bing

Investors in Inovio Pharmaceuticals Inc. (INO) saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the INO options chain for the new October 16th contracts …
The Street · 23 hours ago
Inovio Pharmaceuticals (NASDAQ:INO) Director Simon X. Benito bought 6,000 shares of Inovio Pharmaceuticals stock in a transaction that occurred on Friday, August 14th. The stock was purchased at an average price …
Mideast Times · 8/19/2015
Inovalis Real Estate Investment Trust (TSE:INO.UN) Director Raymond Par purchased 4,000 shares of the business’s stock in a transaction on Monday, August 24th. The stock was acquired at an average cost of C$8.72 per share, with a total value of C$ ...
sleekmoney.com · 8/27/2015
More from Bing News
Inovio Pharmaceuticals Inc (NASDAQ:INO) traded up 3.24% during midday trading on Thursday, hitting $7.02. The company’s stock had a trading volume of 943,554 shares. Inovio Pharmaceuticals Inc has a 12 month low of $6.19 and a 12 month high of …
Ticker Report · 1 day ago
MedImmune acquired the rights to INO-3112, which is in early clinical studies as a treatment against cancers of the cervix, head, and neck. The partnership announcement sent the stock soaring, and has the potential to …
NASDAQ · 8/27/2015
Inovio Pharmaceuticals (NASDAQ:INO) Director Simon X. Benito bought 6,000 shares of the firm’s stock in a transaction on Friday, August 14th. The shares were purchased at an average cost of $7.21 per share, with a total value of $43,260.00. Following …
wkrb13.com · 8/18/2015
Source: U.S. Food and Drug Administration. Earnings releases for clinical-stage biotech stocks often prove to be non-events. However, that wasn't the case last week with Inovio Pharmaceuticals (NASDAQ: INO
The Motley Fool · BySean Williams · 8/20/2015
Inovio
Inovio Pharmaceuticals Inc. (INO) was one of the Russell 2000's biggest losers for Monday August 24 as the stock slid 7.04% to $6.54, a loss of $-0.495 per share. Starting at an opening price of $6.50 a share, the stock traded between $6.19 and $7.06 over ...
Equities · 8/24/2015
Inovio Pharmaceuticals Inc
Today, shares of Inovio Biomedical (AMEX:INO) have advanced above their 10-day MA of $7.16 ... price of $7.64 and an average consensus analyst price target of $21.40. The stock should find resistance at its 200-day moving average (MA) of $8.43, as well ...
Financial News Network Online · ByRobert Cotter · 21 hours ago
Inovio Biomedical
Inovio Pharmaceuticals Inc (NASDAQ:INO) rallied 2.69% during the last trading session to settle at $7.64. Its market capitalization has now reached $536.55 Billion. The Biotechnology & Medical Research – NEC …
streetregister.com · 8/20/2015